Another nice study from this group. These longitudinal data provide insight into the rates of brain atrophy in patients with familial AD. They reinforce the notion that a lot of damage occurs prior to clinically recognized disease. If true for typical late onset AD such studies have important implications regarding implementation of disease modifying therapies.
Comments
Goizueta Institute @ Emory Brain Health
Another nice study from this group. These longitudinal data provide insight into the rates of brain atrophy in patients with familial AD. They reinforce the notion that a lot of damage occurs prior to clinically recognized disease. If true for typical late onset AD such studies have important implications regarding implementation of disease modifying therapies.
Make a Comment
To make a comment you must login or register.